Home

Treatment

Read time: 2 min

Congress highlights

CGRP therapies for migraine: What have we learned since launch?

Today is a most exciting time in the migraine field given the plethora of new therapies introduced...

Read time: 2 min

Congress highlights

Steps towards improving quality of life for patients with migraine

Is it necessary to consider both patients and treating physicians’ views when investigating...

Read time: 2 min

Congress highlights

Negative symptoms improved by early intervention

New EPA guidelines on the diagnosis and management of negative symptoms should help draw attention...

How far can technology aid diagnosis and treatment?

Machine learning has potential in aiding objective psychiatric diagnosis and in the prediction of...

How far can technology aid diagnosis and treatment?

Do long-acting injectable antipsychotics have a role in early-phase schizophrenia?

Early intervention and continuous treatment in schizophrenia are key to ensuring good outcomes....

Do long-acting injectable antipsychotics have a role in early-phase schizophrenia?

Read time: 1 min

Congress highlights

How often is migraine a cause of secondary trigeminal neuralgia?

Migraine is the most common underlying cause of secondary trigeminal neuralgia. This is the finding...

Read time: 2 min

World Mental Health Day 2020 — addressing stigma and discrimination to achieve Mental Health for All

The theme for World Mental Health Day 2020 is Mental Health for All: Greater Investment, Greater...

Read time: 2 min

Digital technologies — an opportunity to achieve Mental Health for All

Digital technologies have the potential to transform the theme for World Mental Health Day 2020...

Read time: 2 min

No health without mental health

The 10–25-year lower life expectancy of people with severe mental health disorders compared...

Read time: 2 min

Congress highlights

How far can technology aid diagnosis and treatment?

Machine learning has potential in aiding objective psychiatric diagnosis and in the prediction of...

Read time: 3 min

Congress highlights

Addressing the gender bias in mental health research

There are significant differences between women and men in disease presentation, underlying...

Read time: 2 min

Congress highlights

Forty thousand users and counting: science-based nomenclature takes off

Classifying drugs by mechanism of action rather than by indication should clarify the rationale for...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind

You are leaving Progress in Mind

Continue to

Cancel

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

All the information included in the Website is related to products of the local market and, therefore, directed to health professionals legally authorized to prescribe or dispense medications with professional practice. The technical information of the drugs is provided merely informative, being the responsibility of the professionals authorized to prescribe drugs and decide, in each concrete case, the most appropriate treatment to the needs of the patient.

Accept

Decline

Congress

Register for access to Progress in Mind in your country